Perinatal exposure to morphine disrupts brain norepinephrine, ovarian cyclicity, and sexual receptivity in rats

Pharmacology Biochemistry and Behavior

Volumn 58, Issue 1, 1997, Pages 243-248

  Siddiqui, Arif ^a   Haq, Soofia ^a   Shah, Bukhtiar H ^a  

^a AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

Behavior; Catecholamines; Morphine; Perinatal; Pregnancy; Reproduction

Indexed keywords

ESTRADIOL; MORPHINE; PROGESTERONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BODY WEIGHT; CONTROLLED STUDY; DOSE RESPONSE; ESTRADIOL BLOOD LEVEL; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; LORDOSIS; MENSTRUAL CYCLE; NONHUMAN; NORADRENALIN BRAIN LEVEL; NORADRENERGIC SYSTEM; PREGNANCY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RAT; SEX DIFFERENTIATION; SEXUAL MATURATION;

AMYGDALA; ANALGESICS, OPIOID; ANIMALS; ANIMALS, NEWBORN; BRAIN CHEMISTRY; ESTRADIOL; FEMALE; HYPOTHALAMUS; LUTEINIZING HORMONE; MORPHINE; NOREPINEPHRINE; ORGAN SIZE; OVARY; PREGNANCY; RADIOIMMUNOASSAY; RATS; RATS, WISTAR; SEXUAL BEHAVIOR, ANIMAL; WEIGHT GAIN;

ANIMALIA;

EID: 0030801509     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(97)00012-9     Document Type: Article

References (51)

1. Abel E. L., Bush R., Dintcheff B. A., Ernst C. A. S. Critical periods for marihuana-induced intra-uterine growth retardation in the rat. Neurobehav. Toxicol. Teratol. 3:1981;351-354.
2. Adler B. E., Crowley W. R. Modulation of luteinizing hormone release and catecholamine activity by opiates in the female rat. Neuroendocrinology. 38:1984;248-253.
3. Akabori A., Barraclough C. A. Effect of morphine on luteinizing hormone secretion and catecholamine turnover in the hypothalamus of estrogen-treated rats. Brain Res. 362:1986;221-226.
4. Avidor-Reiss T., Bayewitch M., Levy R., Matus-Leibovitch N., Nevo I., Vogel Z. Adenylylcyclase supersensitization in mu-opioid receptor-transfected Chinese hamster ovary cells following chronic opioid treatment. J. Biol. Chem. 270:1995;29732-29738.
5. Baron S. A., Testa F. M., Gintzler A. R. Simultaneous quantitation of norepinephrine, dopamine and serotonin in brain during and following chronic naltrexone administration. Brain Res. 340:1985;192-198.
6. Basheer R., Tempel A. Morphine-induced reciprocal alterations in G alpha s and opioid peptide mRNA levels in discrete brain regions. J. Neurosci. Res. 36:1993;551-557.
7. Bigelow G. E., Preston K. L. Opioids. Bloom F. E., Kupfer D. J Psychopharmacology. The fourth generation of progress:1995;1731-1744 Raven Press, Ltd, New York.
8. Chasnoff I. J. Effects of maternal narcotic vs. non narcotic addiction on neonatal neurobehaviour infant development. In: Pinkert, T. M Consequences of maternal drug abuse. 1985;84-95 National Institute of Drug Abuse, Washington, DC.
9. Chiara G. D., North R. A. Neurobiology of opiate abuse. Trends Pharmacol. Sci. 13:1992;185-193.
10. Clendeninn N., Petraits M., Simon E. J. Ontological development of opiate receptors in rodent brain. Brain Res. 118:1976;157-160.
11. Crowell R., Solomon J., Drieze J. Effect of neonatal administration of estradiol benzoate (EB) or delta-9-THC on female rats. Marihuana '84. 1985;567-572 Oxford Press IRL, Oxford, UK.
12. Dohler K. D. The pre- and postnatal influences of hormones and neurotransmitters on sexual differentiation of the mammalian hypothalamus. Int. Rev. Cytol. 131:1991;1-57.
13. Fields A., Gafni M., Oron Y., Sarne Y. Multiple effects of opiates on intracellular calcium level and on calcium uptake in three neuronal cell lines. Brain Res. 687:1995;94-102.
14. Gorski R. A., Gordon J. H., Shryne J. E., Southam A. M. Evidence for a morphological sex difference within the medial preoptic area of the rat brain. Brain Res. 148:1978;333-336.
15. Gulati K. Differential effects of intrahypothalamic administration of opioids on food intake in naive and tolerant rats. Pharmacol. Biochem. Behav. 52:1995;689-694.
16. Haney M., Miczek K. A. Morphine effects on maternal aggression, pup care and analgesia in mice. Psychopharmacology. 98:1989;68-74.
17. He J. R., Molnar J., Barraclough C. A. Evidence that amplification of norepinephrine-induced LH release by morphine is indirectly due to suppression of tuberoinfundibular dopamine secretion. Brain Res. 653:1994;1-8.
18. Heishman S. J., Stitzer M. L., Bigelow G. E., Liebson I. A. Acute opioid physical dependence in post-addict humans. Naloxone dose effects after brief morphine exposure J. Pharmacol. Exp. Ther. 248:1989;127-134.
19. Heishman S. J., Stitzer M. L., Bigelow G. E., Liebson I. A. Acute opioid physical dependence in humans. Effect of varying the morphine-naloxone interval J. Pharmacol. Exp. Ther. 250:1989;485-491.
20. Hutchings D. E. Methadone and heroin during pregnancy. A review of behavioural effects in human and animal offspring Neurobehav. Toxicol. Teratol. 4:1982;429-434.
21. Kalra S. P. Neural loci involved in naloxone-induced luteinizing hormone release. Effects of a norepinephrine synthesis inhibitor Endocrinology. 109:1981;1805-1810.
22. Kalra S. P., Kalra P. S. Opioid-adrenergic-steroid connection in regulation of luteinizing hormone secretion in the rat. Neuroendocrinology. 38:1984;418-426.
23. Kendle K. E., Paterson J. R., Wilson C. A. The effect of RMI 12,936, a synthetic antiprogestational steroid on the oestrous cycle and ovulation in the rat. J. Reprod. Fertil. 53:1978;363-368.
24. Lakhman S. S., Singh R., Kaur G. Morphine-induced inhibition of ovulation in normally cycling rats. Neural site of action Physiol. Behav. 46:1989;467-471.
25. MacDonald M. C., Wilkinson M. Occurrence of sexual maturation in chronic opiate-treated female rats. J. Endocrinol. 129:1991;253-259.
26. Martinez-Pinero M. G., Milanes V., Alcaraz C., Vargas M. L. Catecholaminergic mediation of morphine-induced activation of pituitary-adrenocortical axis in the rat. Implication of α- and β-adrenoceptors Brain Res. 668:1994;122-128.
27. Mateo A. R., Hijazi M., Hammer R. P. Dynamic patterns of medial preoptic μ-opiate receptor regulation by gonadal steroid hormones. Neuroendocrinology. 55:1992;51-57.
28. Matsuoka I., Maldonado R., Defer N., Noel F., Hanoune J., Roques B. B. P. Chronic morphine administration causes region-specific increase of brain type VIII adenylyl cyclase mRNA. Eur. J. Pharmacol. 268:1994;215-221.
29. Mullaney I., Shah B. H., Wise A., Milligan G. Expression of the human β2 adrenoceptor in NCB20 cells results in agonist activation of adenylyl cyclase and agonist-mediated selective down regulation of Gsα J. Neurochem. 65:1995;545-553.
30. Naftolin, F.; Corker, C. S.: An ultra micromethod for the measurement of luteinizing hormone by radioimmunoassay. In: Kirkham, K. E.; Hunter, W. H., eds. Radioimmunoassay methods. Edinburgh: Churchill Livingstone; 1971:614-645.
31. Reisine T., Pasternak G. Opioid analgesics and antagonists. Harden J. G., Gilman A. G., Limbird L. E. The pharmacological basis of therapeutics. 9:1996;521-556 McGraw-Hill, New York.
32. Rimanoczy A., Vathy I. Prenatal exposure to morphine alters brain mu opioid receptor characteristics in rats. Brain Res. 690:1995;245-248.
33. Rubino T., Massi P., Patrini G., Venier I., Giagnoni G., Parolaro D. Effect of chronic exposure to naltrexone and opioid selective agonists on G protein mRNA levels in the rat nervous system. Mol. Brain Res. 23:1994;333-337.
34. Rubino T., Parenti M., Patrini G., Massi P., Parolaro D. Morphine withdrawal syndrome and G protein expression. A study of the time course in the rat central nervous system Eur. J. Neurosci. 7:1995;2334-2340.
35. Shah B. H., McEwan D., Milligan G. Gonadotrophin releasing hormone receptor agonist-mediated down-regulation of Gqα/G11α G-proteins in αT3-1 gonadotroph cells reflects increased G-protein turnover but not alterations in mRNA levels. Proc. Natl. Acad. Sci. USA. 92:1995;1886-1890.
36. Shah B. H., Milligan G. Cyclic AMP differentially regulates the expression of the α-subunit of Gs, Gq and G11 G-proteins and their mRNA levels in rat C6 glioma cells. Biochem. Soc. Trans. 22:1994;10S.
37. Shah B. H., Milligan G. The gonadotrophic releasing hormone receptor of αT3-1 cells regulates cellular levels of both of the phosphoinositidase C-linked G-proteins, Gqα and G11α equally. Mol. Pharmacol. 46:1994;1-7.
38. Siddiqui A., Gilmore D. P. Regional differences in catecholamine content of the rat brain. Effect of neonatal castration and androgenization Acta Endocrinol. 118:1988;483-494.
39. Siddiqui A., Haq S., Shaharyar S., Haider S. G. Morphine induces reproductive changes in female rats and their male offspring. Reprod. Toxicol. 9:1995;143-151.
40. Sklair-Tavron L., Nestler E. J., Segal M. Locus coeruleus (LC)-target interaction and cAMP in control of LC development. Brain Res. Bull. 35:1994;397-402.
41. Smart D., Smith G., Lambert D. G. Mu-opioid receptor stimulation of inositol. trisphosphate formation via a pertussis toxin-sensitive G protein J. Neurochem. 62:1994;1009-1014.
42. Solomon J., Schoenfeld D. The uterotropic effect of THC in ovariectomized rats and mice. Res. Commun. Chem. Pathol. Pharmacol. 29:1980;603-611.
43. Stolerman I. Drugs of abuse. Behavioural principles, methods and terms Trends Pharmacol. Sci. 13:1992;170-176.
44. Swaab D. F., Hofman M. A. Sexual differentiation of the human hypothalamus in relation to gender and sexual orientation. Trends Neurosci. 18:1995;265-270.
45. Vaccarino F. J., Mogil J. S., Stinus L. Chronic dopamine antagonism facilitates opiate-induced feeding. J. Psychiatry Neurosci. 20:1995;210-214.
46. Vathy I., Katay L. Effects of prenatal morphine on adult sexual behavior and brain catecholamines in rats. Dev. Brain Res. 68:1992;125-131.
47. Vathy I., Rimanoczy A., Eaton R. C., Katay L. Modulation of catecholamine turnover rate in brain regions of rats exposed prenatally to morphine. Brain Res. 662:1994;209-215.
48. Vathy I., van der Plas J., Vincent J. Intra-cranial dialysis and microinfusion studies suggest that morphine may act in the ventromedial hypothalamus to inhibit female sexual behavior. Horm. Behav. 25:1991;354-366.
49. Vito C. C., Fox T. O. Androgen and estrogen receptors in embryonic and neonatal rat brain. Dev. Brain Res. 2:1981;97-110.
50. Wilson G. S., McCreary R., Kean J., Baxter J. C. The development of preschool children of heroin-addicted mothers. A controlled study Pediatrics. 63:1979;135-141.
51. Zhou L., Hammer R. P. Jr. Gonadal steroid hormones upregulate medial preoptic μ-opioid receptors in the rat. Eur. J. Pharmacol. 278:1995;271-274.